Weiss Ratings Reiterates “Sell (D-)” Rating for Neuphoria Therapeutics (NASDAQ:NEUP)

Weiss Ratings Reiterates “Sell (D-)” Rating for Neuphoria Therapeutics (NASDAQ:NEUP)